These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

160 related articles for article (PubMed ID: 17055337)

  • 1. Neurotrophic signaling cascades in the pathophysiology and treatment of bipolar disorder.
    Shaltiel G; Chen G; Manji HK
    Curr Opin Pharmacol; 2007 Feb; 7(1):22-6. PubMed ID: 17055337
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Translating neurotrophic and cellular plasticity: from pathophysiology to improved therapeutics for bipolar disorder.
    Soeiro-de-Souza MG; Dias VV; Figueira ML; Forlenza OV; Gattaz WF; Zarate CA; Machado-Vieira R
    Acta Psychiatr Scand; 2012 Nov; 126(5):332-41. PubMed ID: 22676371
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cellular plasticity cascades: genes-to-behavior pathways in animal models of bipolar disorder.
    Einat H; Manji HK
    Biol Psychiatry; 2006 Jun; 59(12):1160-71. PubMed ID: 16457783
    [TBL] [Abstract][Full Text] [Related]  

  • 4. PKC, MAP kinases and the bcl-2 family of proteins as long-term targets for mood stabilizers.
    Manji HK; Chen G
    Mol Psychiatry; 2002; 7 Suppl 1():S46-56. PubMed ID: 11986995
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The extracellular signal-regulated kinase pathway: an emerging promising target for mood stabilizers.
    Chen G; Manji HK
    Curr Opin Psychiatry; 2006 May; 19(3):313-23. PubMed ID: 16612219
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The Wnt signaling pathway in bipolar disorder.
    Gould TD; Manji HK
    Neuroscientist; 2002 Oct; 8(5):497-511. PubMed ID: 12374432
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Mood stabilizers target cellular plasticity and resilience cascades: implications for the development of novel therapeutics.
    Bachmann RF; Schloesser RJ; Gould TD; Manji HK
    Mol Neurobiol; 2005 Oct; 32(2):173-202. PubMed ID: 16215281
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Emerging experimental therapeutics for bipolar disorder: insights from the molecular and cellular actions of current mood stabilizers.
    Gould TD; Quiroz JA; Singh J; Zarate CA; Manji HK
    Mol Psychiatry; 2004 Aug; 9(8):734-55. PubMed ID: 15136794
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Molecular effects of lithium.
    Quiroz JA; Gould TD; Manji HK
    Mol Interv; 2004 Oct; 4(5):259-72. PubMed ID: 15471909
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Impairments of neuroplasticity and cellular resilience in severe mood disorders: implications for the development of novel therapeutics.
    Manji HK; Duman RS
    Psychopharmacol Bull; 2001; 35(2):5-49. PubMed ID: 12397885
    [TBL] [Abstract][Full Text] [Related]  

  • 11. In vivo evidence in the brain for lithium inhibition of glycogen synthase kinase-3.
    Gould TD; Chen G; Manji HK
    Neuropsychopharmacology; 2004 Jan; 29(1):32-8. PubMed ID: 12942141
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Modulation of CNS signal transduction pathways and gene expression by mood-stabilizing agents: therapeutic implications.
    Manji HK; Bebchuk JM; Moore GJ; Glitz D; Hasanat KA; Chen G
    J Clin Psychiatry; 1999; 60 Suppl 2():27-39; discussion 40-1, 113-6. PubMed ID: 10073385
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Glycogen synthase kinase-3: a target for novel bipolar disorder treatments.
    Gould TD; Zarate CA; Manji HK
    J Clin Psychiatry; 2004 Jan; 65(1):10-21. PubMed ID: 14744163
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comparative analysis of the effects of four mood stabilizers in SH-SY5Y cells and in primary neurons.
    Di Daniel E; Mudge AW; Maycox PR
    Bipolar Disord; 2005 Feb; 7(1):33-41. PubMed ID: 15654930
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Bipolar disorder: leads from the molecular and cellular mechanisms of action of mood stabilizers.
    Manji HK; Moore GJ; Chen G
    Br J Psychiatry Suppl; 2001 Jun; 41():s107-19. PubMed ID: 11450170
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cellular plasticity cascades: targets for the development of novel therapeutics for bipolar disorder.
    Zarate CA; Singh J; Manji HK
    Biol Psychiatry; 2006 Jun; 59(11):1006-20. PubMed ID: 16487491
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Intracellular signaling pathways pave roads to recovery for mood disorders.
    Tanis KQ; Duman RS
    Ann Med; 2007; 39(7):531-44. PubMed ID: 17852035
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Antipsychotics in the treatment of bipolar disorder.
    Singh J; Chen G; Canuso CM
    Handb Exp Pharmacol; 2012; (212):187-212. PubMed ID: 23129333
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Mood stabilizers regulate cytoprotective and mRNA-binding proteins in the brain: long-term effects on cell survival and transcript stability.
    Chen G; Huang LD; Zeng WZ; K Manji H
    Int J Neuropsychopharmacol; 2001 Mar; 4(1):47-64. PubMed ID: 11343630
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The role of Wnt signaling and its interaction with diverse mechanisms of cellular apoptosis in the pathophysiology of bipolar disorder.
    Hu LW; Kawamoto EM; Brietzke E; Scavone C; Lafer B
    Prog Neuropsychopharmacol Biol Psychiatry; 2011 Jan; 35(1):11-7. PubMed ID: 20828594
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.